Illustration: Maura Losch/Axios
ApiJect Systems received $35 million in equipment financing from Trinity Capital, company president Jon Ellenthal tells Axios exclusively.
Why it matters: Prefilled syringes take less time and reduce dosing errors and needle sticks.